Iron Study
We are seeking 40 participants who want to participate in a study where you’ll be taking 1 or 2 capsule(s) for 8 weeks (5 days on, 2 days off) of either a new formula to improve iron status or a placebo. We are looking for persons who have a history of iron deficiency or have struggled to maintain healthy iron levels.
All participants will receive the product and lab testing related to healthy iron levels for free. Participants must be willing to take 1-2 capsule(s) once daily in the morning, and to complete study-related questionnaires and blood work before, once after 4 weeks, and a third time after taking the product for 8 weeks.
All participants will start on the same day and take the supplement for 8 weeks consisting of a 5 days on, 2 days off, regimen.
Upon completion of the study, participants will receive a $300 credit at Qualia Life Sciences.
Participation Requirements:
- Provide voluntary, written, informed consent to participate in the study
- Agree to provide a valid cell phone number and are willing to receive communications through text
- Can read and write English
- Willing to not begin taking any new supplements during the study and continue taking any supplements you are currently using regularly
- Willing to complete questionnaires, records, and diaries associated with the study.
- If a participant has EITHER of the following:
- Ferritin 30 ng/mL (anything under 50 ng/mL is considered suboptimal, but participants with 30 ng/mL should be prioritized)
- Transferrin saturation 20% (anything under 30% is considered suboptimal, but participants with 20% should be prioritized)
Exclusion Criteria:
- Women who are pregnant, breastfeeding, or planning to become pregnant during the trial
- Known food intolerances/allergy to any ingredients in the study product
- Having any of the following conditions: Psychiatric conditions, neurologic disorders, endocrine disorders, irritable bowel disease, cancer
- Having had a significant cardiovascular event in the past 6 months
- Taking monoamine oxidase (MAO) inhibitors, selective serotonin reuptake inhibitors (SSRIs), or any other psychiatric or neurological medicines
- On immunosuppressive therapy
- Individuals who were deemed incompatible with the study plan
- Adults lacking capacity to consent
- Taking any of the following medications:
- Antacids
- Proton pump inhibitors (PPIs)
- Antipsychotics
- Antibiotics
This study is being conducted by Qualia Life Science